RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 154 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | -33.3% | 24,200 | +31.5% | 0.00% | – |
| Q1 2022 | $3,000 | -98.9% | 18,400 | -83.9% | 0.00% | -100.0% |
| Q4 2021 | $267,000 | -39.7% | 114,555 | -15.8% | 0.01% | -50.0% |
| Q3 2021 | $443,000 | -8.1% | 136,022 | +22.4% | 0.01% | -6.7% |
| Q2 2021 | $482,000 | +7.8% | 111,160 | -27.2% | 0.02% | -37.5% |
| Q1 2021 | $447,000 | +17.0% | 152,626 | +13.4% | 0.02% | +118.2% |
| Q4 2020 | $382,000 | +57.2% | 134,618 | +18.5% | 0.01% | -8.3% |
| Q3 2020 | $243,000 | +14.6% | 113,598 | +14.8% | 0.01% | 0.0% |
| Q4 2019 | $212,000 | -81.3% | 98,934 | -69.0% | 0.01% | -70.0% |
| Q3 2016 | $1,132,000 | – | 318,866 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |